Fairmount Funds Management as of Sept. 30, 2020
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 17 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 14.4 | $34M | 1.1M | 32.14 | |
| ACADIA Pharmaceuticals (ACAD) | 11.3 | $27M | 648k | 41.25 | |
| Trillium Therapeutics Com New | 9.4 | $22M | 1.6M | 14.21 | |
| Amicus Therapeutics (FOLD) | 8.7 | $21M | 1.5M | 14.12 | |
| Iovance Biotherapeutics (IOVA) | 8.3 | $20M | 597k | 32.92 | |
| Zogenix Com New | 8.0 | $19M | 1.1M | 17.93 | |
| Axsome Therapeutics (AXSM) | 6.6 | $16M | 220k | 71.25 | |
| Unum Therapeutics Ord | 5.8 | $14M | 6.2M | 2.20 | |
| Allakos (ALLK) | 5.7 | $13M | 165k | 81.45 | |
| Argenx Se Sponsored Adr (ARGX) | 5.6 | $13M | 50k | 262.52 | |
| Karyopharm Therapeutics (KPTI) | 4.3 | $10M | 702k | 14.60 | |
| Enanta Pharmaceuticals (ENTA) | 3.1 | $7.4M | 162k | 45.78 | |
| Amarin Corp Spons Adr New (AMRN) | 2.7 | $6.3M | 1.5M | 4.21 | |
| Mirati Therapeutics | 2.5 | $5.8M | 35k | 166.06 | |
| Neoleukin Therapeutics | 1.9 | $4.5M | 373k | 12.00 | |
| Kiniksa Pharmaceuticals Com Cl A | 1.4 | $3.3M | 213k | 15.32 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.3 | $624k | 100k | 6.24 |
